appengine.ai

Artificial Intelligence | Machine Learning | Natural Language Processing BenevolentAI | Re-engineering Drug Discovery


Biotechnology, Pharmaceuticals, Drug Discovery, Clinical Development New York , United States

BenevolentAI

Artificial Intelligence | Machine Learning | Natural Language Processing


BenevolentAI | Re-engineering Drug Discovery

BenevolentAI

Biotechnology, Pharmaceuticals, Drug Discovery, Clinical Development


New York , United States

BenevolentAI is the global leader in the development and application of artificial intelligence (“AI”) for scientific innovation. We aim to accelerate the journey from inventive ideas to medicines for patients by developing AI to generate new treatments for some of the world’s 8,000 untreated diseases.

Our team of technologists, AI researchers, and scientists builds and applies AI to the entire drug discovery and development process. The technology unlocks what is not known by creating new ideas based on established facts to provide a different understanding of disease, which leads to inventive steps and real insights that drive the development of new medicines and treatments.

 

B2B

251 to 500

Series F

$292M

N/A

2013

 
 

Healthcare
Biotechnology

Molecule Design
Knowledge & Reasoning
Target Identification
Precision Medicine

Delivering Life Changing Medicines Faster

 
 

Analytics

Yes

Active

 
 

   Machine Learning
   Natural Language Processing


Sage

Sage

Impraise

Impraise

Spoke

Spoke

Aha

Aha

Asana

Asana

Jira

Jira

Gitlab

Gitlab


Text

Text

Time Series

Time Series

Semi-Structured

Semi-Structured

Structured

Structured

 

   Software


SAML

SAML

SSO

SSO

O365

O365

Okta

Okta

AWS

AWS

GCP

GCP

JAMF

JAMF

Linux

Linux

GSuite

GSuite


Neural Networks

Neural Networks

 
 

Dec 2020

  • Joanna Shields Speaks At The Global Partnership On Artificial Intelligence

Dec 2020

  • BenevolentAI Wins Innovation Award At 2020 Scrip Awards

Dec 2020

  • BenevolentAI Wins Innovation Award At 2020 Scrip Awards

Feb 2020

  • BenevolentAI Announces Scientific Collaboration With UC San Diego To Investigate Cerebral Cavernous Malformations

Sep 2019

  • BenevolentAI draws $90M from Temasek amid reports of halved valuation

Sep 2019

  • BenevolentAI Draws $90M from Temasek Amid Reports of Halved Valuation

Sep 2019

  • BenevolentAI's Latest Financing Could Halve its $2B Valuation ? and that has Woodford Watchers Worried

Sep 2019

  • BenevolentAI announces Agreement with leading healthcare company to leverage BenevolentAI’s technology platform

Apr 2019

  • BenevolentAI Announces New Strategic Partnership With AstraZeneca

Feb 2018

  • BenevolentAI Acquires Advanced Cambridge Research Facility to Accelerate Its AI-enabled Drug Development

Feb 2018

  • BenevolentAI Acquires Advanced Cambridge Research Facility to Accelerate Its AI-enabled Drug Development
 
 

View All

View All AI/ML Jobs

AI Scientist

New York, New York

Machine Learning Engineer

New York, New York

Senior AI Scientist

New York, New York

Lead AI Scientist

London, London

Senior Bioinformatics Data Scientist

New York, New York

 
 
Joanna Shields


Joanna Shields
CEO